|
Volumn 7, Issue , 2012, Pages 19774-
|
Computational analysis to predict functional role of hsa-miR-3065-3p as an antiviral therapeutic agent for treatment of triple infections: HCV, HIV-1, and HBV.
a a a a a a a
a
not available
*
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIVIRUS AGENT;
SMALL INTERFERING RNA;
ARTICLE;
BIOLOGY;
DRUG DEVELOPMENT;
DRUG EFFECT;
GENE EXPRESSION REGULATION;
GENETIC ASSOCIATION;
GENETICS;
HCV;
HEPATITIS B;
HEPATITIS B VIRUS;
HEPATITIS C;
HEPATITIS C VIRUS;
HOMOLOGY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
IDENTITY;
INHIBITION;
METHODOLOGY;
MICRORNA-BASED THERAPY;
MIXED INFECTION;
PHYSIOLOGY;
RNA INTERFERENCE;
RNAI;
SEQUENCE ALIGNMENT;
TRIPLE INFECTION;
VIROLOGY;
VIRUS GENOME;
HBV;
HCV;
HIV-1;
HOMOLOGY;
IDENTITY;
INHIBITION;
MICRORNA-BASED THERAPY;
RNAI;
TRIPLE INFECTION;
ANTIVIRAL AGENTS;
COINFECTION;
COMPUTATIONAL BIOLOGY;
DRUG DISCOVERY;
GENE EXPRESSION REGULATION, VIRAL;
GENOME, VIRAL;
GENOME-WIDE ASSOCIATION STUDY;
HEPACIVIRUS;
HEPATITIS B;
HEPATITIS B VIRUS;
HEPATITIS C;
HIV INFECTIONS;
HIV-1;
HUMANS;
RNA INTERFERENCE;
RNA, SMALL INTERFERING;
SEQUENCE ALIGNMENT;
|
EID: 84880048749
PISSN: None
EISSN: 18196357
Source Type: None
DOI: 10.3402/ljm.v7i0.19774 Document Type: Article |
Times cited : (14)
|
References (0)
|